Repligen Corp. (RGEN)
163.95
+3.28
(+2.04%)
USD |
NASDAQ |
Dec 10, 10:06
Repligen Market Cap: 9.229B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enovis Corp. | 1.544B |
| Teleflex, Inc. | 5.729B |
| Globus Medical, Inc. | 11.96B |
| Perspective Therapeutics, Inc. | 185.85M |
| Xtant Medical Holdings, Inc. | 106.40M |
Market Cap Related Metrics
| PE Ratio | 6354.65 |
| PS Ratio | 13.07 |
| Price to Book Value | 4.430 |
| Price to Free Cash Flow | 89.39 |
| Price | 163.95 |
| Earnings Yield | 0.02% |
| Operating PE Ratio | 197.97 |
| Normalized PE Ratio | 273.07 |